Globus Medical North America Inc develops and manufactures musculoskeletal medical devices for spine, trauma, and orthopedic procedures. Founded in 2003, the company has grown to approximately 5,300–6,000 employees and is listed on the NYSE under the ticker GMED. It operates globally, serving hospitals and surgical centres worldwide.
The company's product portfolio spans spine procedure solutions, orthopedic trauma systems, joint reconstruction devices, and regenerative biologics. A notable offering is ExcelsiusGPS, a robotic navigation technology that assists surgeons in spine and orthopedic procedures. Beyond manufacturing, Globus Medical invests in clinical research and education through partnerships with healthcare professionals and operates state-of-the-art research laboratories.
Globus Medical's strategy emphasises improving surgical outcomes and patient care through innovation in device design and robotic-assisted technology. The company has positioned itself as one of the fastest-growing firms in the orthopedics sector, combining traditional implant manufacturing with emerging technologies in robotic navigation and regenerative medicine.
